And that’s not everything. There’s the impact of health tech, the digital transformation of patient services, the extent to which life sciences is becoming a data science – and more besides.
How can these challenges be addressed?
In this scenario, it’s best to talk to someone who’s been highly active in this field for over 30 years and has over 13,000 specialists.
Life Sciences is a priority at Capgemini, and it’s our fastest-growing sector. Our current footprint includes over 100 global biopharma companies — for which we are delivering end-to-end digital transformation and technology services from strategy to implementation at scale — in over 40 countries.
Our key differentiator is our “people-first” approach, where people (patients, providers, team members, and partners) are at the center of everything we do: from inventing a novel experience for patients to co-creating new operating models and globally implementing a new technology platform.
